🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will assess the efficacy and safety of different treatment regim...
Status
Completed
Location
Multiple Locations
Start Date
2003-06
Trial ID
NCT00074438
Treatments Being Tested
This is a Phase III, multicenter, global, clinical study of an investigatio...
Status
Terminated
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00363636
Treatments Being Tested
The primary objective of this study is to evaluate the progression-free sur...
Status
Terminated
Location
St. Jude Heritage Healthcare Virginia K. Crosson Cancer Center
Start Date
2014-02-05
Trial ID
NCT01980888
Treatments Being Tested
The participants of this study would have relapsed/refractory follicular ly...
Status
Active Not Recruiting
Location
Southern Cancer Center
Start Date
2020-06-11
Trial ID
NCT04224493
Treatments Being Tested
This is a 52 week, single center, randomized, double-blind, placebo-control...
Status
Recruiting
Location
Hospital for Special Surgery
Start Date
2019-07-29
Trial ID
NCT03844061
Treatments Being Tested
This study is a prospective, open-labelled, randomized, controlled, single-...
Status
Recruiting
Location
Peking Union Medical College Hospital
Start Date
2023-06-29
Trial ID
NCT05962840
Treatments Being Tested
Tucidinostat (formerly known as chidamide) is an oral subtype-selective his...
Status
Completed
Location
Peking University Cancer Hospital
Start Date
2020-05-21
Trial ID
NCT04231448
This is a Phase III randomized, double-blind, positive controlled study to ...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2026-03-20
Trial ID
NCT07409428
Treatments Being Tested
Phase 3 randomized, double-blind, placebo-controlled, study assessing the e...
Status
Active Not Recruiting
Location
Research Site
Start Date
2020-10-08
Trial ID
NCT04529772
Treatments Being Tested
The primary objective of this study is to evaluate the effect of the additi...
Status
Completed
Location
Clearview Cancer Institute
Start Date
2012-06-15
Trial ID
NCT01569295
Treatments Being Tested